CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Biogaran against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Nalmefene For Reduction Of Alcohol Consumption In Specific Target PopulationsH LUNDBECKMar 6, 2024
Rapid Dissolution Formulation Of A Calcium Receptor-Active CompoundAMGENAug 30, 2023
Compositions And Uses For Treating Multiple SclerosisBIOGEN IDEC MAApr 20, 2023
S1P Receptor Modulators For Treating Multiple SclerosisNOVARTISJan 13, 2023
Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGYJan 14, 2022
Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICADec 23, 2021
Rapid Dissolution Formulation Of Cinacalcet HclAMGENJan 31, 2020
Rapid Dissolution Formulation Of A Calcium Receptor-Active CompoundAMGENJan 17, 2020
Rapid Dissolution Formulation Of A Cinacalcet HclAMGENJan 17, 2020
Rapid Dissolution Formulation Of Cinacalcet HclAMGENJan 17, 2020

Top competitors of Biogaran

List of top competitors of Biogaran based on patent oppositions.